Current HIV/AIDS Reports

Papers
(The median citation count of Current HIV/AIDS Reports is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Adventures in COVID-19 Policy Modeling: Education Edition65
Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory50
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review48
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?47
Challenges and Opportunities in Big Data Science to Address Health Inequities and Focus the HIV Response43
Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries40
Syndemic Theory and Its Use in Developing Health Interventions and Programming: A Scoping Review40
Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review32
Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic31
Ethical Perspectives in Using Technology-Enabled Research for Key HIV Populations in Rights-Constrained Settings28
Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States25
Interventions to Improve Adolescent HIV Care Outcomes25
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?24
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 202022
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review22
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure22
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa22
Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don’t21
Technology-Delivered Intervention Strategies to Bolster HIV Testing21
Risk Compensation in Voluntary Medical Male Circumcision Programs21
Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy20
The Value of Assessing Self-Reported and Biological Indicators of Outcomes in Evaluating HIV Programs20
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program19
Update on Central Nervous System Effects of HIV in Adolescents and Young Adults19
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview18
PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice18
A Review of Serious Gaming as an Intervention for HIV Prevention17
Transition to Adult Care for Young People Living with HIV17
Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV17
Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa15
Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence15
VMMC Programmatic Successes and Challenges: Western Kenya Case Study15
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions14
Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy14
Intervention Approaches to Address Intimate Partner Violence and HIV: a Scoping Review of Recent Research14
Update on Vaccination Recommendations for Adults with HIV14
HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?14
Mpox and HIV: a Narrative Review13
Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead13
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era13
Fatty Liver Disease: Enter the Metabolic Era13
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups12
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations12
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa12
The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies12
Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review12
Advances in HIV Research Using Mass Cytometry11
Voluntary Medical Male Circumcision to Reduce HIV Acquisition and Transmission11
Strategies for Hepatitis B Virus Prevention in People Living with HIV11
Challenges of HIV Management in an Aging Population11
Reporting Individual-Level Research Results from Neurocognitive and Psychological Research in People Living with HIV: Lessons from Dementia Research11
Adherence and HIV Protection Thresholds for Emtricitabine and Tenofovir Disoproxil Fumarate Preexposure Prophylaxis among Cisgender Women: A Systematic Review10
Implementation Science for HIV Prevention and Treatment in Indigenous Communities: a Systematic Review and Commentary10
Updates on HIV and Kidney Disease10
Addressing HIV and Substance Use Health Disparities among Racial/Ethnic Minority Individuals9
The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management9
The End Is in Sight: Current Strategies for the Elimination of HIV Vertical Transmission9
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places9
A Perspective on Home-Based Sexual Health Care: Evidence, Access, and Future Directions9
Integrated Care Models: HIV and Substance Use8
Pharmacological and Behavioral Interventions to Mitigate Premature Aging in Patients with HIV8
Improving Communication: A Narrative Synthesis of Interventions for HIV Disclosure to Pediatric Populations8
Does Voluntary Medical Male Circumcision Reduce HIV Risk in Men Who Have Sex with Men?7
The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV7
Peer-Led Adjunctive Interventions for Increasing the Reach of HIV Prevention and Care Interventions to Latino/x/e Men Who Have Sex with Men: a Scoping Review7
Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update7
Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure7
Social Determinants of Disease: HIV and COVID-19 Experiences6
Transgender Individuals and Digital Health6
Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters6
Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and Syphilis in Pregnancy: the Quest to Eliminate Maternal and Vertical Transmission6
The New Era of Long-Acting Antiretroviral Therapy: When and Why to Make the Switch6
COVID-19 Outcomes and Risk Factors Among People Living with HIV6
Challenges and Solutions to STI Control in the Era of HIV and STI Prophylaxis6
Correction to: A Review of Interventions to Enhance HIV Medication Adherence6
HIV Prevention in Syringe Service Programs Since the Start of COVID-19: Where Do We Go From Here?6
Peer Approaches to Improve HIV Care Cascade Outcomes: a Scoping Review Focused on Peer Behavioral Mechanisms6
CNS Considerations in ART Simplification Strategies6
Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men5
The Role of p53 in HIV Infection5
Overcoming Vaccine Hesitancy for Future COVID-19 and HIV Vaccines: Lessons from Measles and HPV Vaccines5
Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review5
Policies and Practices Facilitating Access to and Uptake of HIV Testing Services among Adolescents in Sub-Sahara Africa: A Narrative Review5
Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV5
Point-of-Care Syphilis Testing: Implementation and Future Direction5
How Does Voluntary Medical Male Circumcision Reduce HIV Risk?5
Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome4
Sustaining HIV Research in Resource-Limited Settings Using PLAN (People, Learning, Adapting, Nurturing): Evidence from the 4 Youth by Youth Project in Nigeria4
Implementation Strategies for Digital HIV Prevention and Care Interventions for Youth: A Scoping Review4
Paradata: Measuring Engagement in Digital HIV Interventions for Sexual and Gender Minorities4
Metabolic Complications Associated with Use of Integrase Strand Transfer Inhibitors (InSTI) for the Treatment of HIV-1 Infection: Focus on Weight Changes, Lipids, Glucose and Bone Metabolism4
Interventions to Reduce Alcohol Use and HIV Risk among Sexual and Gender Minority Populations: a Systematic Review3
Antimicrobial Resistance in Curable Sexually Transmitted Infections3
Increasing Access To Sexually Transmitted Infection Testing: The Promise of Point-of-Care and Over-the-Counter Tests3
Diabetes in HIV: the Link to Weight Gain3
Digital Strategies Supporting Social Network Approaches to HIV Testing: A Scoping Review3
A 5-Year Review of the Impact of Lottery Incentives on HIV-Related Services3
Ongoing Healthcare Disparities in neuroHIV: Addressing Gaps in the Care Continuum3
Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations3
A Review of Implementation Strategies to Enhance PrEP Delivery for People Experiencing Housing Insecurity: Advancing a Multifaceted High-Touch, Low-Barrier Approach3
Using Behavioral Economics to Support PrEP Adherence for HIV Prevention3
Lessons Learned from Longer Acting Reversible Contraception Applied to Longer Acting HIV Prevention Technologies3
0.064122915267944